Product Information
TEMAZEPAM 15 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.0767 per EA under NDC 43547061250. Its NADAC has been published 164 times since Aug 16, 2023.
FDA first approved this application on Jun 4, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547061250
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA201781FDA Approved
6/4/2015
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 15 MG CAPSULE has been published 164 times since Aug 16, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0767 per EA |
|---|---|
| All-time high | $0.0793 (Aug 12, 2026) |
| All-time low | $0.0548 (Nov 20, 2024) |
| 52-week high | $0.0793 |
| 52-week low | $0.0756 |
| Median price | $0.0756 |
| Average price | $0.0730 |
| Largest weekly change | -29.8% (Nov 20, 2024) |
| Weeks tracked | 164 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
temazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 15 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $0.0767 per EA (NDC 43547061250), effective Sep 30, 2026.
How has the price of TEMAZEPAM 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 15 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 164 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 15 MG CAPSULE?
Since Aug 16, 2023, the NADAC for TEMAZEPAM 15 MG CAPSULE has ranged from a low of $0.0548 (Nov 20, 2024) to a high of $0.0793 (Aug 12, 2026), with a median of $0.0756 per EA.
Are there cheaper alternatives to TEMAZEPAM 15 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 15 MG CAPSULE?
TEMAZEPAM 15 MG CAPSULE (NDC 43547061250) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.